Stock Events

Stock Events

Nuvation Bio 

$0
72
+$0+0% Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

4MayExpected
Q3 2025
Q4 2025
Next
-0.17
-0.12
-0.07
-0.03
Expected EPS
-0.028045
Actual EPS
N/A

Financials

-7,213.76%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
15.75MRevenue
-1.14BNet Income

Analyst Ratings

11.57Average Price Target
The highest estimate is 17.00.
From 7 ratings within the last 6 months. This is not an investment recommendation.
Buy
71%
Hold
29%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow NUVB-WT.BOATS. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Bristol-Myers Squibb
BMY
Mkt Cap122.85B
Bristol Myers Squibb is a leading biopharmaceutical company focusing on cancer treatments, directly competing with Nuvation Bio's oncology focus.
Merck
MRK
Mkt Cap294.39B
Merck & Co., Inc. specializes in cancer drugs and vaccines, making it a direct competitor in the oncology space.
Pfizer
PFE
Mkt Cap156.77B
Pfizer Inc. has a broad portfolio including oncology, directly competing with Nuvation Bio's cancer-focused therapies.
Gilead Sciences
GILD
Mkt Cap170.84B
Gilead Sciences, Inc. focuses on antiviral drugs and cancer therapies, positioning it as a competitor in the oncology market.
AMGEN
AMGN
Mkt Cap191.53B
Amgen Inc. has a strong presence in the oncology and hematology market, competing with Nuvation Bio's cancer treatments.
Abbvie
ABBV
Mkt Cap368.57B
AbbVie Inc. has a diverse biopharmaceutical portfolio including oncology, making it a competitor in the cancer treatment space.
Regeneron Pharmaceuticals
REGN
Mkt Cap79.35B
Regeneron Pharmaceuticals, Inc. is known for its innovative treatments in oncology, competing with Nuvation Bio's cancer therapies.
Astrazeneca
AZN
Mkt Cap317.5B
AstraZeneca PLC has a strong oncology portfolio, directly competing with Nuvation Bio in the development of cancer treatments.
Novartis
NVS
Mkt Cap293.34B
Novartis AG focuses on a wide range of healthcare areas including oncology, making it a competitor in the cancer treatment market.
Johnson & Johnson
JNJ
Mkt Cap564.35B
Johnson & Johnson operates in various healthcare sectors, including oncology, competing with Nuvation Bio's focus on cancer therapies.

About

Nuvation Bio, Inc. is a biopharmaceutical company tackling some of the unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its proprietary portfolio includes six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer. The company was founded by David Hung on March 20, 2018 and is headquartered in New York, NY.
Show more...
CEO
ISIN
US67080N1191

Listings

XNYS
US
NUVB
BOATS
BOATS
NUVB-WT.BOATS
BOATS
BOATS
NUVB.BOATS

0 Comments

Share your thoughts

FAQ

What is Nuvation Bio stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Nuvation Bio stocks are traded under the ticker NUVB-WT.BOATS.
When is the next Nuvation Bio earnings date?▼
Nuvation Bio is going to release the next earnings report on May 04, 2026.
What were Nuvation Bio earnings last quarter?▼
NUVB-WT.BOATS earnings for the last quarter are -0.11 USD per share, whereas the estimation was -0.09 USD resulting in a -23.6% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Nuvation Bio revenue for the last year?▼
Nuvation Bio revenue for the last year amounts to 15.75M USD.
What is Nuvation Bio net income for the last year?▼
NUVB-WT.BOATS net income for the last year is -1.14B USD.
In which sector is Nuvation Bio located?▼
Nuvation Bio operates in the Other sector.
When did Nuvation Bio complete a stock split?▼
Nuvation Bio has not had any recent stock splits.